| scholarly article | Q13442814 |
| P50 | author | Paul Greengard | Q309979 |
| Vincent Paillé | Q48306705 | ||
| Maria Viscomi | Q56501879 | ||
| Carmelo Sgobio | Q60619673 | ||
| Barbara Picconi | Q42663948 | ||
| Fabrizio Gardoni | Q42788443 | ||
| Monica Di Luca | Q42788457 | ||
| Veronica Ghiglieri | Q42883463 | ||
| P2093 | author name string | Paolo Calabresi | |
| Giorgio Bernardi | |||
| Vincenza Bagetta | |||
| Massimiliano Di Filippo | |||
| Carmela Giampà | |||
| Francesca R Fusco | |||
| P2860 | cites work | Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions | Q44193907 |
| Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. | Q44365334 | ||
| Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 | ||
| A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia | Q44560865 | ||
| Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. | Q44842409 | ||
| Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. | Q44931344 | ||
| Direct measurement of somatic voltage clamp errors in central neurons. | Q46541078 | ||
| Voltage- and space-clamp errors associated with the measurement of electrotonically remote synaptic events | Q46598947 | ||
| A 6-hydroxydopamine-induced selective parkinsonian rat model | Q46617652 | ||
| Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
| Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight | Q47226476 | ||
| Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias | Q48306624 | ||
| Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons | Q48496524 | ||
| Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression | Q48617011 | ||
| Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test | Q59574528 | ||
| Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity | Q63256021 | ||
| Short- and long-term synaptic depression in rat neostriatum | Q72665515 | ||
| Unilateral dopamine denervation blocks corticostriatal LTP | Q73280384 | ||
| C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors | Q73870745 | ||
| LTP and LTD | Q22337342 | ||
| The glutamate receptor ion channels | Q28137916 | ||
| Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor | Q28202320 | ||
| Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 | ||
| A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia | Q28569068 | ||
| Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor | Q28577705 | ||
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| PDZ domain proteins of synapses | Q29616399 | ||
| Parkinson's disease. First of two parts | Q29620416 | ||
| Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
| Electrophysiology of dopamine in normal and denervated striatal neurons | Q34070888 | ||
| Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway | Q34133059 | ||
| Dopamine depletion impairs precursor cell proliferation in Parkinson disease. | Q34326801 | ||
| Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
| Dopamine-dependent synaptic plasticity in striatum during in vivo development | Q34658296 | ||
| Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 | ||
| Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease | Q36821186 | ||
| Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease | Q36998952 | ||
| Molecular mechanisms of L-DOPA-induced dyskinesia | Q37247578 | ||
| Molecular mechanisms underlying levodopa-induced dyskinesia. | Q37264455 | ||
| Memories of NMDA receptors and LTP. | Q40400027 | ||
| Postsynaptic density protein-95 regulates NMDA channel gating and surface expression. | Q40493453 | ||
| Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors | Q41051191 | ||
| Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat. | Q41079201 | ||
| The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments | Q41277031 | ||
| Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions | Q42170132 | ||
| Long-term synaptic depression in the striatum: physiological and pharmacological characterization | Q42453585 | ||
| Bidirectional activity-dependent plasticity at corticostriatal synapses. | Q42487664 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| striatum | Q1319792 | ||
| synaptic plasticity | Q1551556 | ||
| P304 | page(s) | 14182-14193 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition | |
| P478 | volume | 30 |
| Q54389154 | "Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease. |
| Q57296786 | A competitive model for striatal action selection |
| Q38174986 | A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease |
| Q48491950 | Ammonia-induced deficit in corticostriatal long-term depression and its amelioration by zaprinast |
| Q36034592 | Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum |
| Q37683163 | Beta Oscillatory Changes and Retention of Motor Skills during Practice in Healthy Subjects and in Patients with Parkinson's Disease. |
| Q47920457 | CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease. |
| Q37117817 | Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum |
| Q55071517 | Centrality of Early Synaptopathy in Parkinson's Disease. |
| Q34180506 | Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol |
| Q42177230 | Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia |
| Q48332145 | Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat. |
| Q42444141 | Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism |
| Q48114419 | Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. |
| Q50420863 | Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum |
| Q38837604 | Early synaptic dysfunction in Parkinson's disease: Insights from animal models. |
| Q45981012 | Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat. |
| Q49193847 | Exercise-Induced Fatigue Impairs Bidirectional Corticostriatal Synaptic Plasticity |
| Q36894599 | Functional Uncoupling NMDAR NR2A Subunit from PSD-95 in the Prefrontal Cortex: Effects on Behavioral Dysfunction and Parvalbumin Loss after Early-Life Stress |
| Q48362193 | GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease |
| Q49246060 | Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates |
| Q48128071 | Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications. |
| Q36341914 | Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activity. |
| Q27002626 | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? |
| Q37516434 | Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia |
| Q40313187 | Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats. |
| Q26830654 | Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases |
| Q38136650 | Motor cortical plasticity in Parkinson's disease. |
| Q41927894 | N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons. |
| Q41420806 | NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients. |
| Q37329730 | Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes. |
| Q38038559 | New synaptic and molecular targets for neuroprotection in Parkinson's disease |
| Q30829270 | Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model |
| Q39647087 | PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity |
| Q28582674 | PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking |
| Q48261352 | Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease |
| Q64901815 | Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease. |
| Q35028568 | Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism |
| Q34961512 | Regulation of dendritic calcium release in striatal spiny projection neurons |
| Q38063779 | Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease. |
| Q64086843 | Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease |
| Q26768220 | Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link? |
| Q92742934 | Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging |
| Q89896340 | Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity |
| Q89948582 | Synaptic and cellular plasticity in Parkinson's disease |
| Q34246880 | The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium spiny neurons |
| Q92918998 | The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients |
Search more.